DetailsChartProfileRisk matrixNewsDocuments

MAGELLAN I/  FR0011238344  /

Fonds
NAV2024-09-19 Chg.+0.1400 Type of yield Investment Focus Investment company
20.7500EUR +0.68% reinvestment Equity Emerging Markets Comgest ▶
GlobeNewswire 08-29 Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a ...
GlobeNewswire 08-28 Giant Magellan Telescope Mount Fabrication Begins
GlobeNewswire 08-20 Navios Maritime Partners L.P. Reports Financial Results for the Second Quarter and Six Months Ended ...
GlobeNewswire 08-08 Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
GlobeNewswire 08-05 Diamondback Energy, Inc. Announces Second Quarter 2024 Financial and Operating Results
GlobeNewswire 08-01 Gain Therapeutics to Participate at BTIG Virtual Biotechnology Conference
GlobeNewswire 07-16 Howard Hughes Holdings Inc. Appoints Bhupesh Arora as Chief Technology Officer
GlobeNewswire 07-09 Gain Therapeutics Announces the Completion of Dosing in the Multiple Ascending Dose (MAD) of the Pha...
GlobeNewswire 06-28 Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024
GlobeNewswire 06-28 Michael Braham appointed CareSource Military & Veterans president
GlobeNewswire 06-27 Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
GlobeNewswire 06-27 Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) For...
GlobeNewswire 06-25 Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
GlobeNewswire 06-14 Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
GlobeNewswire 06-13 Gain Therapeutics Announces Proposed Public Offering
GlobeNewswire 06-13 Giant Magellan Telescope Enclosure Ready for Construction
GlobeNewswire 05-30 Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federati...
GlobeNewswire 05-14 Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire 05-14 Navios Maritime Partners L.P. Reports Financial Results for the First Quarter Ended March 31, 2024
GlobeNewswire 04-24 Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase ...
GlobeNewswire 04-08 Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Offi...
GlobeNewswire 04-01 Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire 03-27 Cegedim Full year 2023 results: Revenue and recurring operating income both up
GlobeNewswire 03-26 Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
GlobeNewswire 03-15 Gain Therapeutics to Present at Public Ventures Discovery Day